CNS Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is…

Biotechnology
US, Houston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

CNS Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

CNS Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of CNS Pharmaceuticals, Inc..

End of CNSP's Analysis
CIK: 1729427 CUSIP: 18978H102 ISIN: US18978H2013 LEI: - UEI: -
Secondary Listings
CNSP has no secondary listings inside our databases.